thiazoles has been researched along with Agnogenic Myeloid Metaplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bledsoe, S; Borthakur, GM; Bose, P; Bueso-Ramos, CE; Carter, BZ; Cortes, J; Daver, NG; DiNardo, CD; Estrov, ZE; Garcia-Manero, G; Jabbour, E; Jain, N; Kadia, TM; Konopleva, MY; Mak, PY; Masarova, L; Ohanian, M; Pemmaraju, N; Pierce, S; Popat, U; Qiao, W; Verstovsek, S; Wang, X; Zhou, L | 1 |
| Beamish, M; Grabek, J; Mohamed, M | 1 |
| Kasada, A; Munemoto, S; Murata, R; Ueda, M; Yamaguchi, M | 1 |
1 trial(s) available for thiazoles and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis.
Topics: Apoptosis; Humans; Myeloproliferative Disorders; Primary Myelofibrosis; Thiazoles | 2021 |
2 other study(ies) available for thiazoles and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Chronic myeloid leukaemia masquerading as primary myelofibrosis.
Topics: Biopsy; Blood Cell Count; Bone Marrow; Dasatinib; Diagnosis, Differential; Genes, abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Primary Myelofibrosis; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2014 |
Successful treatment using low-dose dasatinib for chronic myelogenous leukemia in a patient with megakaryoblastic transformation concomitant with myelofibrosis and an extramedullary tumor.
Topics: Aged; Antineoplastic Agents; Cell Transformation, Neoplastic; Dasatinib; Dose-Response Relationship, Drug; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Primary Myelofibrosis; Pyrimidines; Thiazoles | 2010 |